Dystonia clinical trials
23 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia
- Intrathecal Baclofen and Pediatric Dystonia
- Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
- Investigating Inhibitory Control Networks in Parkinson's Disease
- Deep Brain Stimulation Therapy in Movement Disorders
- Deep Brain Stimulation Surgery for Movement Disorders
- Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
- Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
- Dystonia Genotype-Phenotype Correlation
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Clinical Outcomes for Deep Brain Stimulation
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders
- A Multicenter Pediatric Deep Brain Stimulation Registry
- Brain Networks in Dystonia
- Physiological Brain Atlas Development
- Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
- Understanding Motivation in Parkinson's Patients Through Neurophysiology
- Sleep-specific DBS Therapy in Parkinson's Disease
- Cortical-Basal Ganglia Speech Networks
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
- Effects of Stimulation Patterns of Deep Brain Stimulation
- Deep Brain Stimulation (DBS) MatchMaker
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Dystonia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.